Lilly (Eli) & Co. Contracts & Agreements

153 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Eli Lilly and Company Shareholder Value Award Agreement (Executive Officer) under 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2025
Eli Lilly and Company Relative Value Award Agreement for Executive Officers under the 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2025
Eli Lilly and Company Restricted Stock Unit Award Agreement (for Executive Officer) under the 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2025
Eli Lilly and Company Deferred Compensation Plan (Amended and Restated Effective January 1, 2025)
Compensation Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2025
Eli Lilly and Company Directors' Deferral Plan (Amended and Restated Effective January 1, 2025)
Compensation Agreements
Lilly (Eli) & Co.
Pharmaceuticals
NY
2025
Eli Lilly and Company Underwriting Agreement with Barclays, BofA, Citigroup, Deutsche Bank, and Goldman Sachs (2025)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2025
Eli Lilly and Company Officers’ Certificate Establishing Six Series of Notes under 1991 Indenture
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2025
Eli Lilly and Company Underwriting Agreement with BNP Paribas, Citigroup, Goldman Sachs, J.P. Morgan, and Morgan Stanley (August 2024)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2024
Eli Lilly and Company Officers’ Certificate Establishing Series of Notes under 1991 Indenture
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2024
Eli Lilly and Company Amended and Restated 2002 Stock Plan (as amended May 6, 2024)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2024
Description of Common Stock of Eli Lilly and Company
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2024
Eli Lilly and Company Shareholder Value Award Agreement for Executive Officers under 2002 Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2024
Eli Lilly and Company Relative Value Award Agreement for Executive Officers under 2002 Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2024
Eli Lilly and Company Restricted Stock Unit Award Agreement for Executive Officer under 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2024
Eli Lilly and Company 2007 Change in Control Severance Pay Plan for Select Employees (as Amended Effective January 1, 2024)
Change of Control Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2024
Eli Lilly and Company Underwriting Agreement with BofA Securities, Barclays, Citigroup, Deutsche Bank, and Mizuho (February 2024)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2024
Eli Lilly and Company Officers’ Certificate Establishing Series of Notes under 1991 Indenture
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2024
Eli Lilly and Company Executive Officer Performance Award Agreement under 2002 Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2023
Eli Lilly and Company Shareholder Value Award Agreement for Executive Officers under the 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2023
Eli Lilly and Company Relative Value Award Agreement for Executive Officers under the 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2023
Eli Lilly and Company Non-Compete Payment Agreement with Executive
Non-Competition Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2023
Eli Lilly and Company Executive Officer Performance Award Agreement under 2002 Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Eli Lilly and Company Shareholder Value Award Agreement for Executive Officers under the 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Eli Lilly and Company Relative Value Award Agreement for Executive Officers under 2002 Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Eli Lilly and Company Performance Award Agreement for Executive Officers under the 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Eli Lilly and Company Executive Officer Performance Award Agreement under 2002 Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Eli Lilly and Company Performance Award Agreement for Non-Executive Officers under the 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Eli Lilly and Company Shareholder Value Award Agreement for Executive Officers under 2002 Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Eli Lilly and Company Shareholder Value Award Agreement for Executive Officers (2022-2024)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Eli Lilly and Company Relative Value Award Agreement for Executive Officers under the 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Eli Lilly and Company Relative Value Award Agreement for Executive Officers under 2002 Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Eli Lilly and Company Relative Value Award Agreement for Executives (Non-Executive Officer) under 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Eli Lilly and Company Restricted Stock Unit Award Agreement for Executive Officer under 2002 Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Loxo Oncology, Inc. Bonus Plan (Effective January 1, 2021)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2022
Release Agreement between Eli Lilly and Company and Joshua L. Smiley, Effective February 9, 2021
Release Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2021
Eli Lilly and Company Performance Award Agreement for Executive Officers under the 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Eli Lilly and Company Executive Officer Performance Award Agreement under 2002 Stock Plan (with Non-Compete)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Eli Lilly and Company Performance Award Agreement for Non-Executive Officers under the 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Eli Lilly and Company Shareholder Value Award Agreement for Executive Officers under 2002 Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Eli Lilly and Company Shareholder Value Award Agreement for Executive Officers under 2002 Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Eli Lilly and Company Shareholder Value Award Agreement (Non-Executive Officer) under 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Eli Lilly and Company Relative Value Award Agreement for Executives under the 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Eli Lilly and Company Relative Value Award Agreement for Executives under the 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Eli Lilly and Company Restricted Stock Unit Award Agreement for Executive Officers under the 2002 Lilly Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Eli Lilly and Company Bonus Plan (as Amended Effective August 26, 2020)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2021
Eli Lilly and Company 2007 Change in Control Severance Pay Plan for Select Employees (as Amended January 1, 2018)
Change of Control Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2021
Eli Lilly and Company Performance Award Agreement for Executive Officers under 2002 Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2020
Eli Lilly and Company Shareholder Value Award Agreement for Executive Officers under 2002 Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2020
Eli Lilly and Company Relative Value Award Agreement for Executive Officers under 2002 Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2020
First Amendment to Stock and Asset Purchase Agreement between Novartis AG and Eli Lilly and Company
Purchase Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2015
Eli Lilly and Company Deferred Compensation Plan (Amended and Restated Effective 1/1/2009)
Compensation Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2014
Eli Lilly and Company 2002 Stock Incentive Plan (As Amended Effective January 1, 2009)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2008
Eli Lilly and Company Directors' Deferral Plan (Amended and Restated Effective January 1, 2009)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
NY
2008
Eli Lilly and Company Deferred Compensation Plan (Amended and Restated Effective 1/1/2009)
Compensation Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2008
Eli Lilly and Company 2007 Change in Control Severance Pay Plan for Select Employees (as Amended Effective January 1, 2009)
Change of Control Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2008
Eli Lilly and Company 2007 Change in Control Severance Pay Plan for Select Employees (as Amended October 20, 2010)
Change of Control Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2008
Agreement and Plan of Merger among Eli Lilly and Company, Alaska Acquisition Corporation, and ImClone Systems Incorporated (October 6, 2008)
Merger Agreements
Lilly (Eli) & Co.
Pharmaceuticals
DE
2008
Eli Lilly and Company 2002 Stock Plan (as Amended through April 16, 2007)
Equity Distribution Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2007
Eli Lilly and Company Shareholder Value Award Agreement (2002 Plan)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2007
Eli Lilly and Company $2.5 Billion Debt Securities Underwriting Agreement with Credit Suisse, Deutsche Bank, J.P. Morgan, and Goldman Sachs (March 2007)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2007
Eli Lilly and Company 5.20% Note Due 2017 Certificate (Indenture: Citibank, N.A. as Trustee)
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2007
Eli Lilly and Company 5.50% Note Due 2027 Certificate (Indenture with Citibank, N.A. as Trustee)
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2007
Eli Lilly and Company 5.55% Note Due 2037 Certificate (Indenture with Citibank, N.A. as Trustee)
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2007
Eli Lilly and Company 1994 Stock Plan (as Amended Through April 15, 2002)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2007
Eli Lilly and Company 1998 Stock Plan (As Amended and Restated Effective October 15, 2001)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2007
Eli Lilly and Company Bonus Plan (as Amended October 16, 2006)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2006
Eli Lilly and Company 2007 Change in Control Severance Pay Plan for Select Employees
Change of Control Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2006
Eli Lilly and Company Bonus Plan (as Amended January 1, 2006)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2006
Summary of 2006 Compensation for Non-Employee Directors of Eli Lilly and Company
Compensation Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2006
Summary of 2006 Compensation for Named Executive Officers of Eli Lilly and Company
Compensation Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2006
Eli Lilly and Company Bonus Plan (Amended and Restated January 1, 2005)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2005
Confidential Master Settlement Agreement between Eli Lilly and Zyprexa Claimants' Counsel
Settlement Agreements
Lilly (Eli) & Co.
Pharmaceuticals
NY
2005
Indenture Agreement among Eli Lilly Services, Inc., Eli Lilly and Company, and Citibank, N.A. dated August 9, 2005
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
DC
2005
Officers’ Certificate Establishing 13-Month Floating Rate Extendible Notes under Indenture – Eli Lilly Services, Inc. and Eli Lilly and Company
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
NY
2005
Summary of 2005 Compensation for Non-Employee Directors of Eli Lilly and Company
Compensation Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2005
Summary of 2005 Compensation for Named Executive Officers of Eli Lilly and Company
Compensation Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2005
Retirement and Retiree Medical Benefits Clarification Letter for Charles E. Golden – Eli Lilly and Company
Retirement Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2005
Eli Lilly and Company Letter Agreement Regarding Enhanced Retirement Benefits for Steven M. Paul
Retirement Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2005
Arrangement Regarding Retirement Benefits for Robert A. Armitage and Eli Lilly and Company
Retirement Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2005
Time Sharing Agreement between Eli Lilly and Company and Sidney Taurel (March 4, 2005)
Services Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2005
Eli Lilly and Company Deferred Compensation Plan (Amended and Restated as of April 19, 2004)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2004
Eli Lilly and Company Change in Control Severance Pay Plan for Select Employees (Amended and Restated July 1, 2004)
Change of Control Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2004
Eli Lilly and Company 2007 Change in Control Severance Pay Plan for Select Employees
Change of Control Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2004
Rights Agreement between Eli Lilly and Company and First Chicago Trust Company of New York (July 20, 1998)
Lilly (Eli) & Co.
Pharmaceuticals
NY
2004
Eli Lilly and Company Deferred Compensation Plan (As Amended and Restated January 1, 2004)
Compensation Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2004
Eli Lilly and Company Directors' Deferral Plan (Amended and Restated as of January 1, 2004)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2004
Eli Lilly and Company GlobalShares Stock Plan (As Amended and Restated September 17, 2002)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2003
Eli Lilly and Company 2.90% Note Due 2008 (Indenture with Citibank, N.A. as Trustee)
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2003
Eli Lilly and Company 4.50% Note Due 2018 (Form of Global Note)
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2003
Eli Lilly and Company 1989 Stock Plan (as Amended Through April 15, 2002)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2002
Eli Lilly and Company 1994 Stock Plan (as Amended Through April 15, 2002)
Equity Distribution Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2002
Eli Lilly and Company 1994 Stock Plan (as Amended through October 15, 2001)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2001
Eli Lilly and Company 1998 Stock Plan (As Amended and Restated Effective October 15, 2001)
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2001
Eli Lilly and Company Change in Control Severance Pay Plan for Select Employees (Amended and Restated October 15, 2001)
Change of Control Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2001
Eli Lilly and Company Chairman Salary Reduction and Benefits Preservation Agreement (Sidney Taurel, 2002)
Compensation Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2001
Eli Lilly and Company 1989 Stock Incentive Plan (as Amended through October 18, 1993)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2001
Eli Lilly and Company EVA Bonus Plan (As Amended and Restated Effective January 1, 2001)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2001
Eli Lilly and Company Underwriting Agreement with J.P. Morgan, Credit Suisse, Goldman Sachs, and Morgan Stanley (February 2023)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2023
Eli Lilly and Company Officers’ Certificate Establishing Four Series of Notes under 1991 Indenture
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2023
Description of Eli Lilly and Company’s 0.500%, 1.125%, and 1.375% Euro-Denominated Notes Due 2033, 2051, and 2061
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2022
Eli Lilly and Company 1.625% Notes Due 2043—Description of Debt Securities
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2022
Eli Lilly and Company Shareholder Value Award Agreement (Non-Executive Officer) under 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2022
Eli Lilly and Company Underwriting Agreement with Merrill Lynch International, Barclays, BNP Paribas, Citigroup, and Deutsche Bank (September 2021)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Eli Lilly and Company Officers’ Certificate Establishing Four Series of Notes under 1991 Indenture
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2021
Eli Lilly and Company Restricted Stock Unit Award Agreement for Executive Officer under 2002 Lilly Stock Plan
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2021
Underwriting Agreement between Eli Lilly and Company and Underwriters for $1.1 Billion Notes Offering (2020)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2020
Eli Lilly and Company Officers’ Certificate Establishing 2.500% Notes Due 2060 and Additional 2.250% Notes Due 2050 under Indenture
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Underwriting Agreement between Eli Lilly and Company and BofA Securities, Barclays, Credit Suisse, and Goldman Sachs (April 24, 2020)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2020
Eli Lilly and Company Officers’ Certificate Establishing 2.250% Notes Due 2050 under Indenture with Deutsche Bank Trust Company Americas
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Description of Eli Lilly and Company Common Stock and Related Shareholder Rights
Stock Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Description of Eli Lilly and Company’s 1.000% Notes Due 2022, 1.625% Notes Due 2026, and 2.125% Notes Due 2030
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Description of Eli Lilly and Company 6.77% Notes Due 2036
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Description of Eli Lilly and Company 7 1/8% Notes Due 2025
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Description of Eli Lilly and Company’s 0.625% and 1.700% Euro Notes Due 2031 and 2049
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2020
Restricted Stock Unit Award Agreement between Eli Lilly and Company and Michael Harrington under the 2002 Lilly Stock Plan
Equity Distribution Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2020
Underwriting Agreement between Eli Lilly and Company and Underwriters for €1.6 Billion Notes Offering (2019)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2019
Eli Lilly and Company Officers’ Certificate Establishing 0.625% and 1.700% Euro Notes under 1991 Indenture
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2019
Eli Lilly and Company Shareholder Value Award Agreement for Executive Officers (2019 Grant)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2019
Eli Lilly and Company Performance Award Agreement for Executive Officers (2019 Grant)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2019
Amended and Restated 2002 Lilly Stock Plan (Effective May 7, 2018)
Equity Distribution Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2018
Eli Lilly and Company Performance Award Agreement for Executive Officers (2018–2021)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2018
Eli Lilly and Company Shareholder Value Award Agreement for Executive Officers (2018-2020)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2018
Eli Lilly and Company Underwriting Agreement with J.P. Morgan, Merrill Lynch, and Morgan Stanley (May 2017)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2017
Eli Lilly and Company Officers’ Certificate Establishing Series of Notes under Indenture (May 2017)
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2017
Eli Lilly and Company Performance Award Agreement for Executive Officers (2017–2020)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2017
Eli Lilly and Company Shareholder Value Award Agreement for Executive Officers (2017–2019)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2017
Eli Lilly and Company Shareholder Value Award Agreement for Executive Officers (2016–2018)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2016
Underwriting Agreement between Eli Lilly and Company and Multiple Underwriters for €2.1 Billion Notes Offering (May 2015)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2015
Eli Lilly and Company Officers’ Certificate Establishing Terms of 2015 Euro-Denominated Notes under Indenture
Note Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2015
Underwriting Agreement between Eli Lilly and Company and Underwriters for $2.2 Billion Notes Offering
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2015
Eli Lilly and Company Officers’ Certificate Establishing Series of Notes under 1991 Indenture
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2015
Eli Lilly and Company Performance Award Agreement for Executive Officers (2015–2016)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2015
Eli Lilly and Company Shareholder Value Award Agreement for Executive Officers (2015–2017)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2015
Eli Lilly and Company Underwriting Agreement with Merrill Lynch, Barclays, and Citigroup (2014)
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2014
Eli Lilly and Company Officers’ Certificate Establishing Terms of 1.950% and 4.650% Notes under 1991 Indenture
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2014
Eli Lilly and Company Bonus Plan (as amended effective January 1, 2014)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2014
Arrangement Regarding Retirement Benefits for Robert A. Armitage
Retirement Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2013
Severance Arrangement for Dr. Jan Lundberg with Eli Lilly and Company
Severance Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2012
Eli Lilly and Company Bonus Plan (As Amended Effective January 1, 2011)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2011
Severance Arrangement for Dr. Jan Lundberg with Eli Lilly and Company
Severance Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2011
Eli Lilly and Company Executive Officer Performance Award Agreement (2010–2011)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2010
Eli Lilly and Company Restricted Stock Unit Award Agreement for Executive Officers (2010)
Equity Distribution Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2010
Eli Lilly and Company Shareholder Value Award Agreement (2010–2012)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2010
Eli Lilly and Company Bonus Plan (as Amended January 1, 2010)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2010
Eli Lilly and Company Exit Agreement with Steven M. Paul, M.D.
Separation Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2010
Underwriting Agreement between Eli Lilly and Company and Underwriters for 2012, 2014, and 2037 Notes
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
NY
2009
Eli Lilly and Company Officers’ Certificate Establishing Terms of 3.550% Notes Due 2012, 4.200% Notes Due 2014, and 5.950% Notes Due 2037 under Indenture with Deutsche Bank...
Underwriting Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2009
Instrument of Resignation, Appointment and Acceptance among Eli Lilly and Company, Citibank, N.A., and Deutsche Bank Trust Company Americas
Indenture Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2009
Eli Lilly and Company Bonus Plan (Amended January 1, 2009)
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2009
Guilty Plea Agreement Between United States of America and Eli Lilly and Company Regarding Zyprexa Promotion
Settlement Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2009
Settlement Agreement among United States, Relators, and Eli Lilly and Company Regarding Zyprexa Marketing Practices
Settlement Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2009
Corporate Integrity Agreement between Eli Lilly and Company and the Office of Inspector General, HHS
Settlement Agreements
Lilly (Eli) & Co.
Pharmaceuticals
2009
Eli Lilly and Company 2009–2010 Performance Award Agreement under 2002 Stock Plan
Bonus & Incentive Agreements
Lilly (Eli) & Co.
Pharmaceuticals
IN
2008